Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-069802
Filing Date
2025-05-13
Accepted
2025-05-13 07:30:25
Documents
92
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-20250331.htm   iXBRL 10-Q 2670091
2 EX-31.1 itrm-ex31_1.htm EX-31.1 18291
3 EX-31.2 itrm-ex31_2.htm EX-31.2 18551
4 EX-32.1 itrm-ex32_1.htm EX-32.1 10949
5 EX-32.2 itrm-ex32_2.htm EX-32.2 10941
  Complete submission text file 0000950170-25-069802.txt   11575661

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20250331.xsd EX-101.SCH 1911938
95 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20250331_htm.xml XML 1825898
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 25937144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)